BeStock  
股票 › 生物科技 › INCY

因赛特制药 INCY

美股市值排名 #819生物科技CAR-T疗法
$119.65 +$1.64 (+1.39%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $120.00 +0.29%
开盘$116.38
昨收$118.01
当日区间$115.00 – $119.81
成交量1.49M
市值$24.39B
市盈率(TTM)61.0
股息率–

基本面

最新报告季度:Q2, ended Jun 2026

营收$1.67B+37.7% YoY
营业利润$700.39M+125.3% YoY
净利润$585.61M+44.6% YoY
摊薄每股收益$2.81+37.7% YoY
自由现金流$495.25M+1,829.5% YoY
经营现金流$507.66M

营收,近8个季度

$1.1BSep '24$1.2BDec '24$1.1BMar '25$1.2BJun '25$1.4BSep '25$1.5BDec '25$1.3BMar '26$1.7BJun '26

净利润,近8个季度

$106.5MSep '24$201.2MDec '24$158.2MMar '25$405.0MJun '25$424.2MSep '25$299.3MDec '25$303.3MMar '26$585.6MJun '26

各季度摊薄每股收益

0.54Sep '241.02Dec '240.80Mar '252.04Jun '252.11Sep '251.46Dec '251.47Mar '262.81Jun '26

各季度自由现金流

$293.2MSep '24$363.8MDec '24$262.9MMar '25$25.7MJun '25$519.6MSep '25$521.4MDec '25$354.2MMar '26$495.2MJun '26

年度营收

$2.7BFY20$3.0BFY21$3.4BFY22$3.7BFY23$4.2BFY24$5.1BFY25

盈利能力与资产负债表

毛利率92.6%
营业利润率31.6%
净利率27.7%
净资产收益率30.7%
资产收益率23.5%
投入资本回报率28.5%
流动比率4.59
负债/资产比率19.4%
现金及投资$4.54B
总负债$28.42M
净现金(净负债)$4.51B
自由现金流/营收32.5%

利润表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
报告营业总收入 $1.67B $1.27B $5.14B $1.51B $1.37B
营业总收入 $1.67B $1.27B $5.14B $1.51B $1.37B
营业成本 $105.00M $104.50M $372.10M $121.10M $99.00M
毛利润 $1.57B $1.17B $4.77B $1.39B $1.27B
营业费用 $868.65M $844.00M $3.43B $1.00B $835.68M
销售及管理费用 $351.70M $328.10M $1.38B $390.40M $329.10M
-管理费用 $351.70M $328.10M $1.38B $390.40M $329.10M
研发费用 $516.95M $515.90M $2.05B $611.37M $506.58M
营业利润 $700.39M $324.17M $1.34B $383.96M $431.30M
非经营性利息净收入(支出) $37.54M $33.12M $103.17M $30.17M $26.19M
非经营性利息收入 $38.12M $33.69M $105.60M $30.75M $26.78M
非经营性利息支出 $582,000.00 $569,000.00 $2.43M $582,000.00 $592,000.00
其他收入(支出) $13.58M -$13.68M $218.53M -$24.11M $24.81M
证券出售收益 $9.81M $6.59M $21.31M $18.25M $8.56M
特殊收益(费用) -$2.50M -$23.05M $172.11M -$48.02M $12.20M
-减:重组及并购费用 $2.50M -$168,000.00 -$6.13M -$28.26M -$12.20M
-减:核销 $0.00 $23.21M $76.28M – –
其他非经营性收入(支出) $6.28M $2.77M $25.11M $5.66M $4.04M
税前利润 $751.51M $343.60M $1.66B $389.94M $482.31M
税费 $165.91M $40.27M $377.80M $90.66M $58.14M
净利润 $585.61M $303.33M $1.29B $299.28M $424.17M
持续经营利润 $585.61M $303.33M $1.29B $299.28M $424.17M
归属母公司净利润 $585.61M $303.33M $1.29B $299.28M $424.17M
归属普通股股东净利润 $585.61M $303.33M $1.29B $299.28M $424.17M
基本每股收益 $2.92 $1.52 $6.59 $1.52 $2.17
摊薄每股收益 $2.81 $1.47 $6.41 $1.46 $2.11
-减:其他特殊支出 – – -$242.25M $0.00 –

资产负债表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
总资产 $7.87B $7.34B $6.96B $6.96B $6.33B
流动资产合计 $6.03B $5.48B $5.02B $5.02B $4.28B
现金及现金等价物与短期投资 $4.54B $4.02B $3.58B $3.58B $2.93B
-现金及现金等价物 $3.98B $3.46B $3.10B $3.10B $2.46B
-短期投资 $553.37M $554.71M $482.79M $482.79M $474.81M
应收款 $1.13B $1.05B $1.02B $1.02B $895.89M
-应收账款 $1.13B $1.05B $1.02B $1.02B $895.89M
存货 $112.54M $115.62M $101.06M $101.06M $83.45M
其他流动资产 $253.09M $301.31M $317.83M $317.83M $368.73M
非流动资产合计 $1.85B $1.85B $1.93B $1.93B $2.05B
固定资产净值 $735.03M $746.84M $758.41M $758.41M $826.79M
-固定资产原值 $1.14B $1.14B $1.13B $1.13B $1.19B
-累计折旧 -$403.91M -$389.00M -$375.07M -$375.07M -$360.60M
投资及预付款 $104.39M $54.58M $47.99M $47.99M $21.87M
-长期股权投资 $104.39M $54.58M $47.99M $47.99M $21.87M
商誉及其他无形资产 $236.20M $243.16M $250.13M $250.13M $275.01M
-商誉 $133.00M $133.00M $133.00M $133.00M $155.59M
-其他无形资产 $103.20M $110.16M $117.13M $117.13M $119.42M
一年以上递延资产 $336.86M $452.52M $515.29M $515.29M $528.14M
其他非流动资产 $433.60M $357.75M $362.25M $362.25M $400.66M
负债合计 $1.53B $1.72B $1.79B $1.79B $1.68B
流动负债合计 $1.31B $1.49B $1.52B $1.52B $1.34B
应付款 $252.64M $234.56M $214.69M $214.69M $177.44M
-应付账款 $250.40M $228.62M $209.94M $209.94M $171.93M
-应付税款合计 $2.24M $5.93M $4.76M $4.76M $5.51M
一年内应计费用 $267.51M $279.92M $287.86M $287.86M $243.53M
短期债务及融资租赁负债 $9.85M $10.02M $10.21M $10.21M $10.39M
-一年内到期融资租赁负债 $9.85M $10.02M $10.21M $10.21M $10.39M
一年内预提费用 $526.44M $722.41M $642.47M $642.47M $599.86M
其他流动负债 $107.35M $117.83M $131.87M $131.87M $139.26M
非流动负债合计 $216.12M $226.62M $275.33M $275.33M $340.43M
长期债务及融资租赁负债 $28.42M $29.41M $30.20M $30.20M $30.88M
-长期融资租赁负债 $28.42M $29.41M $30.20M $30.20M $30.88M
其他非流动负债 $187.70M $197.20M $245.13M $245.13M $309.55M
股东权益合计 $6.34B $5.62B $5.17B $5.17B $4.65B
股东权益 $6.34B $5.62B $5.17B $5.17B $4.65B
股本 $201,000.00 $200,000.00 $198,000.00 $198,000.00 $196,000.00
-普通股 $201,000.00 $200,000.00 $198,000.00 $198,000.00 $196,000.00
-优先股 $0.00 $0.00 $0.00 $0.00 $0.00
资本公积 $5.22B $5.08B $4.93B $4.93B $4.72B
留存收益 $1.10B $517.10M $213.77M $213.77M -$85.51M
不影响留存收益的损益 $19.72M $22.31M $25.46M $25.46M $14.56M

现金流量表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
经营活动现金流 $507.66M $369.35M $1.41B $543.30M $559.39M
持续经营经营活动现金流净额 $507.66M $369.35M $1.41B $543.30M $559.39M
持续经营净利润 $585.61M $303.33M $1.29B $299.28M $424.17M
折旧、折耗与摊销 $26.48M $23.80M $93.29M $23.98M $24.02M
递延税款 $115.62M $63.42M $247.69M $13.50M $124.12M
其他非现金项目 $4.11M $12.60M $8.73M -$16.85M -$5.54M
营运资金变动 -$281.61M -$91.34M -$527.16M $103.20M -$60.42M
-应收款变动 -$73.80M -$27.03M -$170.77M -$128.50M -$53.00M
-存货变动 -$11.88M -$12.23M -$58.51M -$4.86M -$5.56M
-预付资产变动 -$14.04M $9.19M -$156.24M $65.04M -$72.84M
-应付账款及应计费用变动 -$181.89M -$61.28M -$141.64M $171.52M $70.97M
投资活动现金流净额 -$51.79M -$88.20M -$102.61M -$37.42M -$47.42M
持续经营投资活动现金流净额 -$51.79M -$88.20M -$102.61M -$37.42M -$47.42M
资本支出 -$12.41M -$10.20M -$58.87M -$21.88M -$14.75M
无形资产购置及出售净额 $0.00 -$5.00M -$25.00M $0.00 -$25.00M
投资购置及出售净额 -$39.38M -$73.00M -$18.74M -$15.54M -$7.67M
筹资活动现金流 $65.46M $84.82M $101.04M $137.74M -$12.78M
持续经营筹资活动现金流净额 $65.46M $84.82M $101.04M $137.74M -$12.78M
债务发行及偿还净额 -$1.16M -$1.18M -$4.54M -$1.16M -$1.14M
股票期权行使所得 $75.15M $97.93M $221.76M $160.21M $43.43M
其他筹资费用净额 -$8.53M -$11.92M -$116.18M -$21.31M -$55.07M
期末现金余额 $3.98B $3.46B $3.10B $3.10B $2.46B
现金净变动 $521.33M $365.97M $1.41B $643.62M $499.20M
期初现金余额 $3.46B $3.10B $1.69B $2.46B $1.96B
汇率变动影响 -$84,000.00 -$2.69M -$1.71M -$801,000.00 $841,000.00
自由现金流 $495.25M $354.15M $1.33B $521.42M $519.64M
持续经营损益 – – -$21.31M -$18.25M -$8.56M
普通股发行净额 – – $0.00 $0.00 –

讨论区

暂无评论——快来第一个聊聊 INCY。

登录后参与讨论。

Scroll to Top